FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.
about
Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerSerum response factor: positive and negative regulation of an epithelial gene expression network in the destrin mutant corneaIs fibroblast growth factor receptor 4 a suitable target of cancer therapy?Expression of ERG protein in prostate cancer: variability and biological correlates.In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancerFGF23 promotes prostate cancer progression.The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progressionA Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.Endocrine fibroblast growth factor FGF19 promotes prostate cancer progressionAndrogen-responsive serum response factor target genes regulate prostate cancer cell migration.Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-CXCR4-dependent manner.Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.The role of transcription factors in prostate cancer and potential for future RNA interference therapy.Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.Relationship between serum response factor and androgen receptor in prostate cancer.Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo.MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components.RET Signaling in Prostate Cancer.The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN.FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition.
P2860
Q28388072-4472E9F3-C178-4AAF-B52D-9D20C1B056DEQ33672270-EB926BC3-37DE-408A-8AA7-E32B38D0D04FQ33751398-CDAAED89-F5BE-4A63-9BB9-611F2FF3120EQ35608000-7E3B2497-1A43-42D8-95E0-1056360B0BADQ35870855-AB573FAB-2FCE-4B86-BFEF-E9430EA4FB4BQ36232035-82EAF081-E55F-49E8-A27F-C135E5E468C4Q36294460-60BF0A9D-DA66-4F4B-935E-79D663BC42B2Q36303927-D7073FAF-844C-41CA-9B0F-86BE14A5CE02Q36594039-5C8C7F8C-64A6-41EC-8FE1-A18AF034AA30Q36778095-6FB2F894-8E19-4B98-A27D-2B1EEA2CE826Q37065350-6C49DED3-C3D3-473A-A9EC-543DDAD09F20Q37264491-243DF6AD-E778-4551-8F4F-905B23B8D023Q37564655-36B2BF42-E2EA-4A04-94FF-F8190B142E78Q37626205-99A7360A-FD0B-42C5-BA59-69C0D7A0E83EQ37701569-0DA7D5A0-5D08-4E01-8B2B-5822FEA46422Q38198726-9B45C6CE-A013-4D7F-83C0-89AF9DB35577Q38318104-7E7EDDCC-E872-44A5-8148-17102C730EF8Q38734374-76713872-F23C-4A2C-A2B0-BD44B6A58C03Q38845729-012F033A-07D2-46D3-92F9-1684530C032EQ38871314-69E3BC45-BD2B-446A-A7C5-4BE4E18B7831Q39312424-B9925996-8F6D-4679-8FFA-8620B833FCA1Q41125664-DF743C53-B849-4F13-AAD1-21C5DC1A9749Q41972051-575EB076-710B-4F3C-97F2-3E1BBC7769C0Q47552580-45B293BA-389A-4D14-9301-74EE4913C011Q47890656-881EA5E4-AA3F-48AB-8521-3464B26306FBQ49306280-9B872F69-78F8-4242-B0F3-66D891238C02Q52723926-F514F8A1-D3F4-427E-BBD2-A37A59C74103Q52960616-70D27C7E-D3D6-4F6D-A203-E75D3E8A3F1D
P2860
FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@en
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@nl
type
label
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@en
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@nl
prefLabel
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@en
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@nl
P2093
P2860
P1476
FGFR-4 Arg³⁸⁸ enhances prostat ...... rum response factor signaling.
@en
P2093
Anna Frolov
Chad J Creighton
Gustavo Ayala
Jianghua Wang
Michael Ittmann
Olga Dakhova
Wendong Yu
P2860
P304
P356
10.1158/1078-0432.CCR-10-2858
P407
P577
2011-05-27T00:00:00Z